10mg 2x/day during 7 days, then 5mg 2x/day.
- Hypersensitivity to the active substance or to any of the excipients.
- Clinically significant active bleeding.
- Liver diseases associated with coagulopathy and clinically relevant bleeding risk with severe hepatic impairment (Child Pugh C).
- Attention to drug interactions and inhibitors of CYP3A4 and / or P-gp.